New attack on tough breast cancer: radiation supercharges immune therapy
NCT ID NCT06492759
Summary
This study is testing whether adding a short, high-dose course of radiation to standard immunotherapy and chemotherapy can better control an aggressive type of breast cancer that has spread. It will involve about 29 patients whose cancer has a specific marker (PD-L1 positive). The main goal is to see if this combination can keep the cancer from growing for at least a year and shrink tumors in areas not directly treated with radiation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE IV BREAST CANCER AJCC V8 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Emory University Hospital/Winship Cancer Institute
Atlanta, Georgia, 30322, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.